Form 8-K - Current report:
SEC Accession No. 0001087294-13-000006
Filing Date
2013-06-14
Accepted
2013-06-14 16:50:49
Documents
3
Period of Report
2013-06-14
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8kacetadotelabelchange.htm 8-K 36863
2 EXHIBIT-ACETADOTE PRESS RELEASE EXHIBIT a991pressrelease-acetadote.htm EX-99.1 16938
3 cumberlandpicture.jpg GRAPHIC 35104
  Complete submission text file 0001087294-13-000006.txt   103329
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 13914820
SIC: 2834 Pharmaceutical Preparations